Skip to main content
Tanaya Shree, MD, Oncology, Portland, OR

TanayaShreeMD

Oncology Portland, OR

Physician

Dr. Shree is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Shree's full profile

Already have an account?

  • Office

    3181 SW Sam Jackson Park Rd
    Portland, OR 97239
    Phone+1 503-494-7999
    Fax+1 650-498-6205

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology and Medical Oncology, 2014 - 2017
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2012 - 2015
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 2012

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2022 - 2025
  • CA State Medical License
    CA State Medical License 2013 - 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Site to Site Comparison of Follicular Lymphoma Biopsies By Single Cell RNA Sequencing
    Tanaya Shree, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • A Phase I/II Trial of Intratumoral CpG, Local Low-Dose Radiation, and Oral Ibrutinib in Patients with Low-Grade B-Cell Lymphoma 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Dynamic Immune Modulation Seen By Single Cell RNA-Sequencing of Serial Lymphoma Biopsies in Patients Undergoing in Situ Vaccination 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Prior Treatment with Cancer Drug Likely Renders COVID-19 Vaccine Ineffective, Study Finds
    Prior Treatment with Cancer Drug Likely Renders COVID-19 Vaccine Ineffective, Study FindsFebruary 2nd, 2022